News

Celebrating Volunteer Excellence: Breakthrough T1D Awards Announced

Celebrating Volunteer Excellence: Breakthrough T1D Awards Announced

Celebrating the Impact of Dedicated Volunteers

Breakthrough T1D, the prominent organization advocating for and researching type 1 diabetes (T1D), recently celebrated the remarkable achievements of its volunteer leaders at the annual One Conference. This year's event took place with enthusiasm and recognition, as seven exceptional volunteers were honored for their unwavering commitment and significant contributions that have propelled the organization's mission forward.

Highlighting Outstanding Volunteer Contributions

The award recipients included individuals who have dedicated their time and efforts to advance Breakthrough T1D's goals. Their impactful work resonates within the T1D community, motivating others to join the cause. Aaron Kowalski, PhD, the CEO of Breakthrough T1D, expressed gratitude towards these volunteers, emphasizing their role in driving mission-focused progress and life-changing breakthroughs aimed at curing, preventing, and treating type 1 diabetes.

A Closer Look at Awards Presented

Among the honorees, the Carol and Erwin Lurie Award was bestowed upon Jordan Amis. This award holds significant meaning, named after the founders of Breakthrough T1D. Jordan's involvement since 2009, inspired by her son’s diagnosis, showcases her leadership in fundraising, outreach, and service on the Board of Directors. Her dedication led to substantial monetary contributions to pivotal events.

Recognizing Long-Term Commitment

The Dr. Gerald Fishbone Award honored Dayton Coles for his longstanding volunteerism with Breakthrough T1D. Since becoming involved after his daughter's diagnosis, Dayton has significantly shaped the organization’s mission through his various leadership roles, including participation on the International Board of Directors and his contributions to several critical programs.

Engaging the Community: Huntsman Family Community Engagement Award

Another notable recognition was the Huntsman Family Community Engagement Award awarded to Natalie Stanback. Natalie's journey as a caregiver has fueled her passion to advocate for the T1D community. With a longstanding commitment to inclusive practices and community building, she played a pivotal role in fostering a diverse and welcoming environment for all affected by T1D.

Leadership in Challenging Times

The Jim Tyree Award acknowledged Joseph P. Lacher, Jr. for his invaluable leadership, particularly during the pandemic. His proactive efforts helped steer Breakthrough T1D through turbulent times, illustrating the importance of strong guidance and community-focused strategies that maintain momentum and commitment to the mission.

Innovation and Artistic Contributions

Additionally, Shelley and Doug Lowenstein received the John Brady Award for Innovation. Their journey began when their daughter was diagnosed with T1D, leading them to develop initiatives that enhance community engagement and research. Their artistic endeavors also merge science and creativity, raising awareness and funds for T1D research.

Acknowledgment of Courageous Female Leadership

The Mary Tyler Moore Award was awarded to Carol Oxenreiter, recognizing her impactful volunteerism and leadership in advocating for women’s roles within the organization. Carol's commitment stems from her family's journey with T1D, showcasing a blend of personal experience and leadership that empowers others in the community.

About Breakthrough T1D

As a leading force in T1D research and advocacy, Breakthrough T1D is dedicated to improving lives while working toward a cure. The organization invests in research, advocates for policies affecting the T1D community, and educates those affected by this condition. Their efforts play a vital role in advancing therapy and treatment options, providing hope and support to those living with T1D.

Understanding Type 1 Diabetes (T1D)

Type 1 diabetes is an autoimmune disease that significantly impacts insulin production, necessitating lifelong insulin therapy. Despite common misconceptions that T1D primarily affects children, adults can also develop this condition, which is influenced by a complex interaction of genetic and environmental factors. Currently, there is no cure for T1D, underscoring the crucial role Breakthrough T1D plays in advocating for research and resources to benefit the community.

Frequently Asked Questions

What is Breakthrough T1D?

Breakthrough T1D is a global organization dedicated to type 1 diabetes research and advocacy, aiming to improve the lives of those affected and work towards a cure.

How are the volunteers recognized by Breakthrough T1D?

The organization presents several awards annually to recognize the exceptional contributions and leadership of its volunteers.

Who received the Carol and Erwin Lurie Award?

Jordan Amis received this award for her impactful contributions to the organization, especially in fundraising and community outreach.

What does the Dr. Gerald Fishbone Award recognize?

This award is given to individuals for their exemplary long-term commitment and service to Breakthrough T1D's mission.

How does Breakthrough T1D support the T1D community?

Breakthrough T1D invests in research, advocates for policies, and educates individuals to improve the lives of those living with type 1 diabetes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 21

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 26

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading